All Stories

  1. CR4056, a first-in-class Imidazoline I2 ligand, counteracts osteoarthritis chronic pain in rats

    Article • Journal of Pain Research, May 2017, Dove Medical Press

    dr gianfranco caselli, Marco Lanza

  2. CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats

    Article • Journal of Pain Research, June 2012, Taylor & Francis

    Marco Lanza, dr gianfranco caselli

  3. Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain

    Article • Journal of Pain Research, April 2011, Taylor & Francis

    Marco Lanza, dr gianfranco caselli